|
|
Article: Biopharmaceutical company names vice president business development.
- Article from:
- Cancer Weekly
- Article date:
- December 28, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 DEC 28 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NASDAQ:NABI) announced the appointment of Pamela Joy Barton, PhD, to the position of vice president, business development.
Barton's focus will be in four strategic areas: product licensing and acquisition opportunities, technology licensing and acquisition opportunities, alliances to facilitate the global expansion of markets for our products, and merger and acquisition opportunities.
Barton joins the company from Sosei Co. Ltd., a leading Japanese biopharmaceutical company with significant expertise in drug development, where she was vice president business development responsible for ...